CrossrefInfokarte
The 35% CO2 inhalation panic challenge in early clinical anxiolytic drug development: Addressing current methodological limitations
Psychiatry Research Communications · 2026-12 · 6 (4) · 100286
DOI: 10.1016/j.psycom.2026.100286 ↗Abstract
Kein Abstract verfügbar.
EUVIMED